CFDB - Cystic Fibrosis DataBase

All subcategories » published, non RCT

Point of care lung ultrasound in preschool children with cystic fibrosis: a case-controlled, prospective, pilot study.

primary studies  published, non RCT

Details
  • 2024
  • Crispino AA

Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis.

primary studies  published, non RCT

Details
  • 2024
  • Cohen A

The long-term effect of elexacaftor/tezacaftor/ivacaftor on cardiorespiratory fitness in adolescent patients with cystic fibrosis: a pilot observational study.

primary studies  published, non RCT

Details
  • 2024
  • Stastna N

Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial.

primary studies  published, non RCT

Details
  • 2024
  • Wainwright CE

Airway clearance therapy in the school environment: Retrospective analysis of a cohort of pediatric patients with cystic fibrosis.

primary studies  published, non RCT

Details
  • 2023
  • Byrwa DJ

Echocardiographic assessment of cardiovascular involvements in children with cystic fibrosis.

primary studies  published, non RCT

Details
  • 2024
  • Ghaffaripour H

Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: A retrospective review.

primary studies  published, non RCT

Details
  • 2024
  • Guenther EL

Peri-operative and long-term outcomes of kidney transplantation in patients with cystic fibrosis.

primary studies  published, non RCT

Details
  • 2024
  • O'Kelly JA

Improvement in Lung Clearance Index and Chest CT Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Study.

primary studies  published, non RCT

Details
  • 2023
  • McNally P

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.

primary studies  published, non RCT

Details
  • 2023
  • Grancini V